XML 31 R19.htm IDEA: XBRL DOCUMENT v3.24.3
(Loss) Earnings per Share
 9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
(Loss) Earnings per Share Loss per Share
We did not repurchase any shares of our common stock during the third quarter or first nine months of 2024 or 2023.
The following table presents a reconciliation of the numerator and denominator of basic and diluted loss per share for the three and nine months ended September 30, 2024 and 2023:
Three Months Ended
 September 30,		Nine Months Ended
 September 30,
2024202320242023
(Dollars in thousands, except per share amounts)
Numerator for basic and diluted loss per share:
Net loss$(36,068)$(22,621)$(81,689)$(37,841)
Denominator:
Weighted average common shares outstanding for basic calculation257,694,799 257,090,113 257,568,237 256,987,778 
Weighted average common shares outstanding for diluted calculation257,694,799 257,090,113 257,568,237 256,987,778 
Basic loss per share$(0.14)$(0.09)$(0.32)$(0.15)
Diluted loss per share$(0.14)$(0.09)$(0.32)$(0.15)
Basic loss per share is calculated by dividing net loss by the weighted average number of common shares outstanding, which included 527,672 and 477,786 shares of participating securities in the three and nine months ended September 30, 2024, respectively, and 282,891 and 257,953 shares of participating securities in the three and nine months ended September 30, 2023, respectively. Diluted loss per share is calculated by dividing net loss by the sum of the weighted average number of common shares outstanding plus the additional common shares that would have been outstanding if potentially dilutive securities had been issued.
The weighted average common shares outstanding for the diluted loss per share calculation for the three and nine months ended September 30, 2024 excludes the dilutive effect of approximately 26,925 and 50,695 shares, respectively, and 68,991 and 36,148 shares for the three and nine months ended September 30, 2023, respectively, primarily related to restricted stock units (“RSUs”), as their inclusion would have been anti-dilutive due to the Company’s net loss.
Additionally, the weighted average common shares outstanding for the diluted loss per share calculation excludes consideration of 5,566,426 and 4,907,705 equivalent shares for the three and nine months ended September 30, 2024, respectively, and 3,306,665 and 3,135,380 equivalent shares for the three and nine months ended September 30, 2023, respectively, as their effect would have been anti-dilutive.